NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

注射器及注射針的全球市場 - 各產品:2020年∼2026年 (MedCore)

Global Syringes & Needles Market Analysis - Global - 2020-2026 - MedCore - Segmented by: Product (Conventional, Safety & Insulin Devices)

出版商 iData Research Inc. 商品編碼 1000939
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
注射器及注射針的全球市場 - 各產品:2020年∼2026年 (MedCore) Global Syringes & Needles Market Analysis - Global - 2020-2026 - MedCore - Segmented by: Product (Conventional, Safety & Insulin Devices)
出版日期: 2020年12月23日內容資訊: 英文
簡介

本報告提供70個國家以上的注射器及注射針企業相關相關調查分析,市場規模,銷售數量,ASP,企業的市場佔有率相關預測相關的系統性資訊。

全球注射器及注射針市場考察

全球注射器及注射針市場,2019年價值68億美元,市場規模的大部分由針頭市場區隔所佔。全球市場規模,由於COVID-19大流行部分擴大,預計2026年超越75億美元。

全球注射器及注射針市場上最大的2個市場,是歐洲和北美。北美的注射器及注射針市場價值,在預測期間內預計緩慢成長。

2020年,Becton Dickinson領先全球注射器及注射針市場,佔市場佔有率整體40%以上。2017年收購C.R. Bard以來,Becton Dickinson是這個市場區隔的主要企業。

調查對象地區:

各地區的詳細內容,可購買獨立報告。以下是對象地區。

北美 (美國、加拿大)

南美 (巴西,墨西哥,哥倫比亞,阿根廷,秘魯,智利,委內瑞拉,其他)

西歐 (德國,法國,義大利,西班牙,瑞士,奧地利,葡萄牙,荷比盧三國,斯堪地那維亞,其他)

中歐、東歐 (波蘭,土耳其,俄羅斯,希臘,捷克,克羅埃西亞,保加利亞,烏克蘭,哈薩克,匈牙利,羅馬尼亞,波羅的海三小國 (愛沙尼亞,拉脫維亞,立陶宛),其他)

中東 (沙烏地阿拉伯,阿拉伯聯合大公國,以色列,伊朗,科威特,卡達,巴林,阿曼,其他)

亞太地區 (中國,日本,韓國,印度,澳洲,新加坡,印尼,馬來西亞,泰國,菲律賓,汶萊,緬甸,柬埔寨,越南,紐西蘭,台灣,香港,其他)

非洲 (南非,埃及,摩洛哥,迦納,奈及利亞,利比亞,蘇丹,烏干達,肯亞,其他)

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_GLVA20_MC_SN

Throughout this medical market research, the publisher analyzed syringes and needles companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.

Global Syringes & Needles Market Insights

In 2019, the global syringe and needle market was valued at $6.8 billion, with the majority of the market size occupied by the needles segment. The global market size is set to expand partially due to the COVID19 pandemic and exceed $7.5 billion in 2026.

Two of the largest global markets for syringes and needles are Europe and North America. The value of the North American syringe and needle market is expected to grow modestly over the forecast period. Market declines will be driven by a contraction in unit sales but limited by mild average selling prices (ASPs) appreciation. Unit sales declines in the insulin syringe segment will apply downward pressure on unit sales of the total syringe market in North America.

In 2020, Becton Dickinson led the global syringes and needles market, with over 40% of the total market share. Since the 2017 acquisition of C.R. Bard, Becton Dickinson has continued to be a major player in this segment. Becton Dickinson is strongest in the hospital segment of the total syringe and needle market, where it was estimated to control over 80% of sales. The company produces billions of syringes and takes advantage of economies of scale to produce and sell syringes at a lower cost than many of its competitors.

Research Regional Coverage

Throughout this research series, the publisher has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific(China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)